Drug: gemcitabine Quarter: 2016Q3
Total Records: 1,060 Number of Pages: 53
DRUGNAME | PT | EventCount |
---|---|---|
GEMCITABINE | Wound infection | 1 |
Gemcitabine (ATLLC) | Ascites | 1 |
Gemcitabine (ATLLC) | Bone marrow failure | 1 |
Gemcitabine (ATLLC) | Drug ineffective | 1 |
Gemcitabine (ATLLC) | Hepatic failure | 1 |
Gemcitabine (ATLLC) | Hyperammonaemic encephalopathy | 1 |
Gemcitabine (ATLLC) | Hypersensitivity | 1 |
Gemcitabine (ATLLC) | Malignant neoplasm progression | 1 |
Gemcitabine Accord | Abdominal pain | 1 |
Gemcitabine Accord | Acute kidney injury | 1 |
Gemcitabine Accord | Anaemia | 1 |
Gemcitabine Accord | Diarrhoea | 1 |
Gemcitabine Accord | Encephalopathy | 1 |
Gemcitabine Accord | Epistaxis | 1 |
Gemcitabine Accord | Gastrooesophageal reflux disease | 1 |
Gemcitabine Accord | Haematotoxicity | 1 |
Gemcitabine Accord | Hyperkalaemia | 1 |
Gemcitabine Accord | Nausea | 1 |
Gemcitabine Accord | Thrombocytopenia | 1 |
GEMCITABINE HYDROCHLORIDE. | Abdominal discomfort | 1 |
Total Records: 1,060 Number of Pages: 53